| Company Name: | Arch Chemicals, Inc. | | Ticker Symbol: | ARJ | | | WWW Address: | www.archchemicals.com |
| CEO: | Michael E. Campbell | | No. of Employees: | 2,504 |
| Common Issue Type: | CS | | Business Description: | Arch Chemicals, Inc. is a global biocides company providing chemistry-based and related solutions to destroy and control the growth of harmful microbes.
|
| | | Industry Information: | CHEMICALS - Specialty Chemicals [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 47.2 |  0.0 | - | - | | 47.22 | 47.19 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,200.4 | 25.4 | 1.20 | 2.80 | 0.80 | 18.5 | 1.7 | 47.76 - 32.70 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 47.20 | $ | | PE Ratio - LTM | 18.5 | |
| Market Capitalisation | 1,200.4 | mil |
| Latest Shares Outstanding | 25.4 | mil |
| Earnings pS (EPS) | 2.80 | $ |
| Dividend pS (DPS) | 0.80 | ¢ |
| Dividend Yield | 1.7 | % |
| Dividend Payout Ratio | 29 | % |
| Revenue per Employee | 550,080 | $ |
| Effective Tax Rate | 31.7 | % |
| Float | 22.0 | mil |
| Float as % of Shares Outstanding | 86.4 | % |
| Foreign Sales | 644 | mil |
| Domestic Sales | 734 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 1.50 | % |
| Gross Profit Margin | 32.6 | % |
| EBITDA Margin | 9.9 | % |
| Pre-Tax Profit Margin | 5.7 | % |
| Assets Turnover | 1.2 | % |
| Return on Assets (ROA) | 5.1 | % |
| Return on Equity (ROE) | 13.1 | % |
| Return on Capital Invested (ROCI) | 7.6 | % |
| Current Ratio | 2.7 | |
| Leverage Ratio (Assets/Equity) | 2.6 | |
| Interest Cover | 5.8 | |
| Total Debt/Equity (Gearing Ratio) | 0.74 | |
| LT Debt/Total Capital | 42.0 | % |
| Working Capital pS | 16.25 | $ |
| Cash pS | 5.19 | $ |
| Book-Value pS | 19.54 | $ |
| Tangible Book-Value pS | 5.68 | $ |
| Cash Flow pS | 4.18 | $ |
| Free Cash Flow pS | -4.58 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.42 | |
| Price/Tangible Book Ratio | 8.31 | |
| Price/Cash Flow | 11.3 | |
| Price/Free Cash Flow | -10.3 | |
| P/E as % of Industry Group | 75.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.80 |
| Current Dividend Yield | 1.7 |
| 5-Y Average Dividend Yield | 2.5 |
| Payout Ratio | 29.0 |
| 5-Y Average Payout Ratio | 64.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.2 | 101 | 4,253 | 17,480 |
| 4 Weeks | 47.30 | 46.53 | 47.01 | 0.4 | 94 | 4,358 | 82,796 |
| 13 Weeks | 47.34 | 45.94 | 47.18 | 0.0 | 111 | 5,362 | 337,822 |
| 26 Weeks | 47.76 | 32.70 | 39.50 | 19.5 | 131 | 4,899 | 617,235 |
| 52 Weeks | 47.76 | 32.70 | 35.49 | 33.0 | 129 | 3,032 | 760,912 |
| YTD | 47.76 | 32.70 | - | 24.4 | 129 | 3,508 | 712,122 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 47.19 | 47.06 | 46.94 | 41.87 | 40.67 | 1.20 | 1.20 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -0.49 | 6.6 | -2.78 |
| Income | 22.65 | 52.7 | 21.77 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 1.43 | NA | -1.02 |
| Normalized Inc. | 5.86 | NA | 4.06 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 3.9 | 0.5 | -1.0 |
| Earnings % | -9.9 | -12.6 | 50.1 |
| EPS % | -11.4 | -13.9 | 48.9 |
| EPS $ | -0.25 | -0.24 | 0.92 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 27.55 |
| Current Ratio | 2.2 |
| Quick Ratio (Acid Test) | 1.5 |
| Liquidity Ratio (Cash) | 0.76 |
| Receivables Turnover | 7.4 |
| Average Collection Period | 49 |
| Working Capital/Equity | 77.0 |
| Working Capital pS | 13.59 |
| Cash-Flow pS | 4.42 |
| Free Cash-Flow pS | 2.62 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.72 |
| Financial Leverage Ratio (Assets/Equity) | 2.8 |
| Debt Ratio | 64.2 |
| Total Debt/Equity (Gearing Ratio) | 0.83 |
| LT Debt/Equity | 0.74 |
| LT Debt/Capital Invested | 67.0 |
| LT Debt/Total Liabilities | 41.2 |
| Interest Cover | 7.7 |
| Interest/Capital Invested | 1.47 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.39 |
| Tobin's Q Ratio | 0.97 |
| Current P/E Ratio - LTM | 18.50 |
| Enterprise Value (EV)/EBITDA | 11.89 |
| Enterprise Value (EV)/Free Cash Flow | 36.04 |
| Dividend Yield | 1.7 |
| Price/Tangible Book Ratio - LTM | 8.31 |
| Price/Book Ratio - LTM | 2.42 |
| Price/Cash Flow Ratio | 11.3 |
| Price/Free Cash Flow Ratio - LTM | -10.3 |
| Price/Sales Ratio | 0.85 |
| P/E Ratio (1 month ago) - LTM | 18.4 |
| P/E Ratio (26 weeks ago) - LTM | 14.1 |
| P/E Ratio (52 weeks ago) - LTM | 13.0 |
| 5-Y High P/E Ratio | 64.2 |
| 5-Y Low P/E Ratio | 8.0 |
| 5-Y Average P/E Ratio | 26.1 |
| Current P/E Ratio as % of 5-Y Average P/E | 71 |
| P/E as % of Industry Group | 75.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 18.3 |
| PER SHARE FIGURES |
| LT Debt pS | 13.06 |
| Current Liabilities pS | 11.08 |
| Tangible Book Value pS - LTM | 5.68 |
| Book Value pS - LTM | 19.54 |
| Capital Invested pS | 30.31 |
| Cash pS - LTM | 5.19 |
| Cash Flow pS - LTM | 4.18 |
| Free Cash Flow pS - LTM | -4.58 |
| Earnings pS (EPS) | 2.80 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 4.77 |
| Free Cash Flow Margin 5YEAR AVG | 0.25 |
| Net Profit Margin | 5.1 |
| Net Profit Margin - 5YEAR AVRG. | 2.8 |
| Equity Productivity | 3.11 |
| Return on Equity (ROE) | 16.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 10.0 |
| Capital Invested Productivity | 1.79 |
| Return on Capital Invested (ROCI) | 9.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 6.4 |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | 5.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 3.4 |
| Gross Profit Margin | 32.6 |
| Gross Profit Margin - 5YEAR AVRG. | 32.0 |
| EBITDA Margin - LTM | 9.9 |
| EBIT Margin - LTM | 6.9 |
| Pre-Tax Profit Margin | 6.9 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 5.0 |
| Effective Tax Rate | 31.7 |
| Effective Tax Rate - 5YEAR AVRG. | 43.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 122 |
| Revenue per Employee | 550,080 |
| Net Income per Employee | 28,235 |
| Average Collection Period | 55 |
| Receivables Turnover | 7.4 |
| Day's Inventory Turnover Ratio | 67 |
| Inventory Turnover | 5.4 |
| Inventory/Sales | 12.2 |
| Accounts Payble/Sales | 10.48 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 4.04 |
| Fixed Assets Turnover | 2.23 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 6.55 |
| Revenue per $ Plant | 7.80 |
| Revenue per $ Common Equity | 3.11 |
| Revenue per $ Capital Invested | 1.79 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 20.8 |
| Research & Devlopment (R&D) as % of Revenue | 1.5 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 1.5 |
|
|  
|
| |
 |  |
